CNBX Pharmaceuticals Inc.

CNBX Pharmaceuticals Inc.verified

CNBX

Price:

$0.0004

Market Cap:

$37.01K

CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids f...[Read more]

Industry

Biotechnology

IPO Date

2007-09-04

Stock Exchange

OTC

Ticker

CNBX

The PE Ratio as of December 2025 (TTM) for CNBX Pharmaceuticals Inc. (CNBX) is -0.04

According to CNBX Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -95.88% compared to the average of -0.97 of the last 4 quarters.

CNBX Pharmaceuticals Inc. (CNBX) Historical PE Ratio (quarterly & annually)

How has CNBX PE Ratio performed in the past?

The mean historical PE Ratio of CNBX Pharmaceuticals Inc. over the last ten years is -8.60. The current -0.04 PE Ratio has changed -53.47% with respect to the historical average. Over the past ten years (40 quarters), CNBX's PE Ratio was at its highest in in the February 2019 quarter at 3.07. The PE Ratio was at its lowest in in the February 2017 quarter at -279.84.

Quarterly (TTM)
Annual

Average

-8.60

Median

-2.28

Minimum

-58.22

Maximum

30.40

CNBX Pharmaceuticals Inc. (CNBX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CNBX Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 571.24%

Maximum Annual PE Ratio = 30.40

Minimum Annual Increase = -204.82%

Minimum Annual PE Ratio = -58.22

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.14-46.50%
2024-0.27571.24%
2023-0.04-96.40%
2022-1.12-84.85%
2021-7.37114.20%
2020-3.44-111.32%
201930.40-204.82%
2018-29.00-50.18%
2017-58.22247.35%
2016-16.76-49.94%

CNBX Pharmaceuticals Inc. (CNBX) Average PE Ratio

How has CNBX PE Ratio performed in the past?

The current PE Ratio of CNBX Pharmaceuticals Inc. (CNBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.15

5-year avg

-1.79

10-year avg

-8.60

CNBX Pharmaceuticals Inc. (CNBX) PE Ratio vs. Peers

How is CNBX’s PE Ratio compared to its peers?

CNBX Pharmaceuticals Inc.’s PE Ratio is less than GeneLink, Inc. (-0.00), less than Endonovo Therapeutics, Inc. (-0.01), less than Microart Inc. (0), greater than RVL Pharmaceuticals plc (-0.05), less than Acura Pharmaceuticals, Inc. (-0.01), less than Tian'an Pharmaceutical Co., Ltd. (670.29), less than Itoco Inc. (-0.03), greater than Filament Health Corp. (-0.53), less than Affymax, Inc. (-0.00), greater than Naturally Splendid Enterprises Ltd. (-0.26),

Build a custom stock screener for CNBX Pharmaceuticals Inc. (CNBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CNBX Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CNBX Pharmaceuticals Inc. (CNBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CNBX Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is CNBX Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for CNBX Pharmaceuticals Inc. (CNBX)?

What is the highest PE Ratio for CNBX Pharmaceuticals Inc. (CNBX)?

What is the 3-year average PE Ratio for CNBX Pharmaceuticals Inc. (CNBX)?

What is the 5-year average PE Ratio for CNBX Pharmaceuticals Inc. (CNBX)?

How does the current PE Ratio for CNBX Pharmaceuticals Inc. (CNBX) compare to its historical average?